In order to find promising targets in diverse cancer types, we examined how tumor-infiltrating immune cells correlate with inhibitory molecules, including the receptors CTLA4, PD-1, LAG3, and TIM3, and the ligands PD-L1/2, B7-H3/4. Here, HAVCR2 is linked to cancer.